Join the Homeopathy Plus Newsletter
Information, news, & discounts
Subscribe!


Study: Homeopathy for Drug-resistant Tuberculosis

Diagnosis - Tuberculosis. Medical Report with Composition of Medicaments - Red Pills, Injections and Syringe. Selective Focus.

Multi drug resistant-tuberculosis, resistant to Isoniazid and Rifampicin, is a major global public health problem. Homeopathy may be a solution. Patient outcomes were significantly improved when homeopathy was added to their treatment regime.

Health authorities are concerned about the growing number of multi-drug resistant tuberculosis cases around the world. The disease is re-emerging in countries where it had been all but wiped out.

India is not immune to this problem and its researchers have conducted a study to assess what happens when homeopathy is added to the standard allopathic (conventional) treatment of this troubling disease.

And the results of this randomized, double blind, placebo controlled clinical trial? Improved outcomes for sufferers.

Those who received homeopathy with their conventional treatment did much better than those with only placebo added to their regime.

The researchers noted that there was significant improvement in participants chest x-rays. Their weight and haemoglobin levels also improved and erythrocyte sedimentation rates (ESR) fell.

Most significant of all was that the rate of cure in the homeopathy add-on group was 11.4% higher than it was in the placebo add-on group.

Would the results have been any different if only the homeopathy had been used? Possibly but that question will have to be answered by further research.

What we do know is that historically, homeopathy was regularly used forthe treatment of tuberculosis symptoms, and reportedly with good effect.

Without it we would not have the significant writings and repertory from one or our early homeopaths, Clemens Von Boenninghausen, who only came to homeopathy after he was cured by it of end-stage tuberculosis.

More Information: Homeopathic treatment in addition to standard care in multi drug resistant pulmonary tuberculosis: a randomized, double blind, placebo controlled clinical trial